Controversies
Controversies tied to this brand in public sources. A listing is not a finding of fault.
Back to profile2 entries
2022
Huoxiang Zhengqi Water flagged by NMPA over excessive methanol
In August 2022, the National Medical Products Administration notified 20 batches of drugs as noncompliant, including three batches of Huoxiang Zhengqi Water from Taiji Group subsidiary Nanchong Pharmaceutical with methanol levels exceeding the limit. Taiji Group apologized and recalled 15,677 boxes from the unsold portion; drug regulators required a case investigation.
2017
Taiji Group's Chongqing TCM No.2 Factory penalized over substandard Xiao'er Kechuanling Granules
CNR disclosed the Chongqing Food and Drug Administration's fourth enforcement information for 2016: batch 1401003 of Xiao'er Kechuanling Granules produced by Chongqing Traditional Chinese Medicine No.2 Factory had properties that did not meet specifications, was deemed an inferior drug, and illegal gains were confiscated. The incident was limited to the notified batch. Progress: media reported the regulatory enforcement result. Subject: Taiji Group Chongqing Traditional Chinese Medicine No.2 Factory Co., Ltd. Scope: products and administrative enforcement events of its Taiji Group Chongqing Traditional Chinese Medicine No.2 Factory.